Lamotrigin Acis (Lamotrigine)

Lamotrigine blocks voltage‑gated sodium channels on neurons, reducing the rapid influx of sodium ions that triggers abnormal electrical activity. This dampens neuronal excitability, limits glutamate release, and consequently decreases seizure propagation. The same stabilizing effect on neuronal pathways contributes to mood regulation in bipolar disorder.

The dose of Lamotrigin Acis is individualized by the prescribing clinician based on factors such as the patient’s age, weight, type of seizure, co‑administered medications, and renal or hepatic function. Initial dosing typically starts low and is titrated upward to achieve therapeutic effect while minimizing side effects.

Safety data for lamotrigine in pregnancy and lactation are limited, and the pregnancy category is listed as unknown. Clinicians must weigh potential benefits against risks, and women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To place an order, submit an enquiry on the Lamotrigin Acis product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with carbamazepine, lamotrigine has a lower risk of hyponatremia and fewer drug‑induced liver enzyme elevations, but it may cause skin reactions. Valproate often provides broader seizure coverage but carries higher risks of weight gain, teratogenicity, and hepatotoxicity. Choice of therapy depends on seizure type, comorbidities, and individual tolerability.

Lamotrigin Acis should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, temperature‑controlled environment helps maintain its potency throughout its shelf life.

Lamotrigin Acis is taken orally, usually as a tablet, with or without food. The prescribing physician determines the exact dosing schedule, which may involve once‑daily or divided doses. Patients should swallow the tablet whole and avoid crushing or chewing unless specifically instructed.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood dyscrasias like agranulocytosis, hepatic failure, and the emergence of suicidal thoughts or behaviors. Patients should seek immediate medical attention if they notice rash, fever, jaundice, or mood changes.

Lamotrigin Acis is contraindicated in individuals with a known hypersensitivity to lamotrigine or any of its excipients. Caution is also advised for patients with severe hepatic impairment, uncontrolled cardiac arrhythmias, or those taking interacting medications that could markedly increase lamotrigine levels without proper monitoring.